These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12594820)

  • 1. Circulating levels of sex steroid hormones and risk of ovarian cancer.
    Lukanova A; Lundin E; Akhmedkhanov A; Micheli A; Rinaldi S; Zeleniuch-Jacquotte A; Lenner P; Muti P; Biessy C; Krogh V; Berrino F; Hallmans G; Riboli E; Kaaks R; Toniolo P
    Int J Cancer; 2003 May; 104(5):636-42. PubMed ID: 12594820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
    Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
    Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
    Lukanova A; Lundin E; Toniolo P; Micheli A; Akhmedkhanov A; Rinaldi S; Muti P; Lenner P; Biessy C; Krogh V; Zeleniuch-Jacquotte A; Berrino F; Hallmans G; Riboli E; Kaaks R
    Int J Cancer; 2002 Oct; 101(6):549-54. PubMed ID: 12237896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
    Lukanova A; Lundin E; Micheli A; Akhmedkhanov A; Rinaldi S; Muti P; Lenner P; Biessy C; Krogh V; Riboli E; Hallmans G; Berrino F; Zeleniuch-Jacquotte A; Toniolo P; Kaaks R
    Cancer Causes Control; 2003 Apr; 14(3):285-92. PubMed ID: 12814208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.
    Schock H; Surcel HM; Zeleniuch-Jacquotte A; Grankvist K; Lakso HÅ; Fortner RT; Kaaks R; Pukkala E; Lehtinen M; Toniolo P; Lundin E
    Endocr Relat Cancer; 2014; 21(6):831-44. PubMed ID: 25270324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.
    Chen T; Surcel HM; Lundin E; Kaasila M; Lakso HA; Schock H; Kaaks R; Koskela P; Grankvist K; Hallmans G; Pukkala E; Zeleniuch-Jacquotte A; Toniolo P; Lehtinen M; Lukanova A
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):324-36. PubMed ID: 21177423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble Fas levels and risk of ovarian cancer.
    Akhmedkhanov A; Lundin E; Guller S; Lukanova A; Micheli A; Ma Y; Afanasyeva Y; Zeleniuch-Jacquotte A; Krogh V; Lenner P; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    BMC Cancer; 2003 Dec; 3():33. PubMed ID: 14690548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum gonadotropins and steroid hormones and the development of ovarian cancer.
    Helzlsouer KJ; Alberg AJ; Gordon GB; Longcope C; Bush TL; Hoffman SC; Comstock GW
    JAMA; 1995 Dec; 274(24):1926-30. PubMed ID: 8568986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormones and subsequent breast cancer in premenopausal women.
    Micheli A; Muti P; Secreto G; Krogh V; Meneghini E; Venturelli E; Sieri S; Pala V; Berrino F
    Int J Cancer; 2004 Nov; 112(2):312-8. PubMed ID: 15352045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study.
    Lukanova A; Toniolo P; Lundin E; Micheli A; Akhmedkhanov A; Muti P; Zeleniuch-Jacquotte A; Biessy C; Lenner P; Krogh V; Berrino F; Hallmans G; Riboli E; Kaaks R
    Int J Cancer; 2002 Jun; 99(4):603-8. PubMed ID: 11992553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma steroid hormones in women with epithelial ovarian carcinoma.
    Mählck CG
    Acta Obstet Gynecol Scand Suppl; 1986; 137():1-31. PubMed ID: 3468734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
    Holl K; Lundin E; Surcel HM; Grankvist K; Koskela P; Dillner J; Hallmans G; Wadell G; Olafsdottir GH; Ogmundsdottir HM; Pukkala E; Lehtinen M; Stattin P; Lukanova A
    Int J Cancer; 2009 Jun; 124(12):2923-8. PubMed ID: 19330837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
    Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.